2
Announcements
Trials
Browse
Landscape
Status
Completed
1
Sponsor Class
INDUSTRY
1
Study Type
Observational
1
Sponsor
Cancer Type
Gastrointestinal
1
Conditions
Breast Neoplasms
4
Leukemia, Myeloid, Acute
3
Colorectal Neoplasms
3
Lymphoma, Non-Hodgkin
2
Carcinoma, Basal Cell
2
Breast Diseases
2
Basal Cell Nevus Syndrome
2
Upper Tract Urothelial Carcinomas
1
Thrombocythemia, Essential
1
Solid Tumors
1
Serous Ovarian Cancer
1
Recurrence
1
Postmenopausal Women With ER+ HER2- Primary Breast Cancer
1
Polycythemia Vera
1
Ovarian Neoplasms
1
Lymphedema
1
Liver Neoplasms
1
Leukemia
1
Immunoglobulin Light-chain Amyloidosis
1
Hypogonadism
1
Glioma
1
Gastric Adenocarcinoma
1
Fatigue Syndrome, Chronic
1
Eunuchism
1
Colonic Neoplasms
1
Amyloidosis
1
Adenoma
1
Interventions
Fluorouracil
219
Leucovorin
202
Oxaliplatin
192
Irinotecan
150
Bevacizumab
110
Capecitabine
94
Cetuximab
90
Folfox protocol
54
Chemotherapy, Adjuvant
36
Panitumumab
30
Colonoscopy
30
pembrolizumab
23
Drug Therapy
23
Nivolumab
22
Magnetic Resonance Spectroscopy
22
Gemcitabine
21
Blood Specimen Collection
20
Radiotherapy
19
Floxuridine
19
Biopsy
19
Neoadjuvant Therapy
18
Laparoscopy
18
IFL protocol
18
Early Intervention, Educational
18
Celecoxib
18
Surveys and Questionnaires
17
Surgical Procedures, Operative
16
Immunohistochemistry
16
Exercise
16
trifluridine tipiracil drug combination
14
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Colonic Neoplasms
×
Drug Evaluation
×
Clear all
NCT05189171
2024-06-28
MODEL-CRC
Xilis, Inc.
Completed
46 enrolled